Patients with metastatic breast or advanced ovarian cancer spend about 7 hours per week on cancer-related tasks, including ...

Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with ...

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs ...

In this exclusive MedPage Today video, Specht is joined via Zoom by study co-lead, Heather Jacene, MD, of Brigham and Women's ...

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Common symptoms that palliative care teams see in patients with metastatic breast cancer include pain, menopausal symptoms, ...

Our top 5 highlights from the 2025 San Antonio Breast Cancer Symposium (SABCS) include articles and interviews introducing ...

Medically reviewed by Doru Paul, MD Metastatic lung cancer is cancer that has spread (metastasized) from the lungs to other ...

In 2025, the FDA approved 73 first-time generic drugs.  Here are the generics and their indication, in order of approval date: Note: The FDA’s information is current as of Dec. 18. 1. Phytonadione ...

Those shocking statistics explain why more and more people are embracing a reimagined breast-cancer-awareness ribbon that thinks beyond pink. Created in 1992 by Alexandra Penney, then editor-in-chief ...

The biotech firm focused on fighting breast cancer was recently selected to the prestigious Charles River Cell & Gene Therapy ...